Clinical trial Recruiting at 1 site Observational Ages 18 and up

Venous congestion and kidney risk after open-heart surgery: a look at VExUS scores

Official title: Evaluation of the Association Between the VEXUS Score and Hemodynamic Status and the Occurrence of Acute Kidney Injury After Open-Heart Surgery

Run by Hanoi Medical University · NCT07805564 · Data updated 2026-11-12

This study tests whether the VExUS ultrasound score can predict acute kidney injury and other outcomes after open-heart surgery in adults.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment135 (estimated)
SponsorHanoi Medical University
Academic / other
Locations1 site (Hanoi, Hanoi)
StatusRecruiting
StartedJanuary 7, 2026
Main results expectedSeptember 30, 2027
Study endsDecember 31, 2027
Registry record updatedSeptember 4, 2026
Trial IDNCT07805564 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years or older undergoing elective or emergent open-heart surgery with cardiopulmonary bypass.

Probably not a fit

Patients with severe preoperative kidney disease, liver disease, or those not undergoing PiCCO monitoring may have limited applicability of findings to their care.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational study enrolls adults undergoing cardiac surgery with cardiopulmonary bypass and tracks postoperative VExUS scores to see if venous congestion relates to AKI and complications. A predefined subgroup with PiCCO monitoring will be analyzed to explore connections between VExUS findings and PiCCO hemodynamic parameters. The aim is to improve understanding of how venous congestion influences outcomes after surgery and whether VExUS could serve as a prognostic tool. All participants will be analyzed for the development of AKI and other postoperative events relevant to recovery. No interventional therapy is mandated by the protocol.

Why it matters

Potential benefit: If successful, VExUS could help clinicians identify patients at higher risk of AKI and guide fluid management after surgery.

How similar studies have gone: Previous work has suggested associations between venous congestion and adverse renal outcomes, but evidence linking VExUS with detailed hemodynamics in cardiac surgery is limited and exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patients aged 18 years or older
* Undergoing elective or emergent open-heart surgery with the use of Cardiopulmonary Bypass (CPB)

Exclusion Criteria:

* Severe tricuspid regurgitation End-stage chronic kidney disease (estimated glomerular filtration rate below 15 mL per minute per 1.73 square meters)
* Preoperative use of an intra-aortic balloon pump (IABP)
* Preoperative use of extracorporeal membrane oxygenation (ECMO) or a ventricular assist device (VAD)
* Liver cirrhosis, portal hypertension, or portal vein thrombosis
* Refusal to participate by the patient or the patient's legally authorized representative

Where it's running

  • Hanoi Medical University Hospital
    Hanoi, Hanoi, Vietnam
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.